Volume | 1,943 |
|
|||||
News | - | ||||||
Day High | 0.503 | Low High |
|||||
Day Low | 0.4685 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Evoke Pharma Inc | EVOK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.498 | 0.4685 | 0.503 | 0.4685 | 0.4788 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
62 | 1,943 | $ 0.4905716 | $ 953 | - | 0.4159 - 2.42 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:04:15 | 5 | $ 0.4959 | USD |
Evoke Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.98M | 8.48M | - | 5.18M | -7.79M | -0.92 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Evoke Pharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EVOK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.53 | 0.569899 | 0.4159 | 0.4955046 | 25,233 | -0.0615 | -11.60% |
1 Month | 0.5949 | 0.675 | 0.4159 | 0.5595515 | 25,309 | -0.1264 | -21.25% |
3 Months | 0.6194 | 0.76 | 0.4159 | 0.651619 | 43,185 | -0.1509 | -24.36% |
6 Months | 1.27 | 1.49 | 0.4159 | 0.7811294 | 39,300 | -0.8015 | -63.11% |
1 Year | 2.05 | 2.42 | 0.4159 | 1.08 | 30,578 | -1.58 | -77.15% |
3 Years | 1.65 | 5.96 | 0.2261 | 1.13 | 580,524 | -1.18 | -71.61% |
5 Years | 0.728 | 6.0628 | 0.2261 | 1.69 | 566,025 | -0.2595 | -35.65% |
Evoke Pharma Description
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa. |